Deval Lashkari

Deval Lashkari has extensive experience in various leadership roles in the biotechnology and life sciences industry. Since 2001, they have served as a Senior Partner at Telegraph Hill Partners, where they have contributed to the growth and success of the company. In 2022, they joined Mosaic Biosciences as a Board member. Prior to that, they held positions such as Director on the Board of Directors for Excellos, Cell Microsystems, Dynex Technologies, Inc., Nimble Therapeutics, Agena Bioscience, Precision NanoSystems Inc., Asuragen, and Akoya Biosciences, Inc. Their role as CEO and Director at Akoya Biosciences, Inc. further demonstrates their leadership abilities and strategic vision in the industry. Overall, Deval Lashkari has a strong track record of contributing to the success of various organizations in the biotechnology and life sciences sector.

Deval Lashkari holds a Bachelor of Arts degree with Highest Honors in Genetics from the University of California, Berkeley. Additionally, they have pursued further education at Stanford University School of Medicine, specializing in Genetics to obtain a PhD degree. Further details regarding start and end years for these educational experiences are not provided.